Automated immunoassay platforms have transformed the way laboratories handle analytical testing in bioprocess development and manufacturing. By replacing time-intensive manual steps with streamlined automation, these systems enable faster turnaround times, greater accuracy, and reduced variability. But selecting the right platform requires careful consideration. Here, we break down the key factors that can help you make the best choice for your lab while keeping scalability, cost, and efficiency at the forefront.
One of the first decisions to make is whether an open or closed immunoassay platform works better for your operational needs. Each system type offers distinct advantages and is tailored for specific workflows.
A closed platform typically integrates pre-validated kits and reagents designed specifically for the system. Because these systems are pre-optimized, they deliver:
Closed systems offer dependable consistency, making them ideal for labs with strict standardization or those working across multiple locations.
Open platforms, in contrast, provide unparalleled adaptability. These systems allow you to customize workflows, use reagents from multiple suppliers, and scale assays as needed. Key advantages include:
By empowering researchers to modify their processes, open platforms facilitate innovation and ensure your methods stay ahead of evolving requirements.
A versatile platform that supports the entire drug development lifecycle — from discovery to QC — offers significant benefits for cross-departmental collaboration. With a unified system, teams experience:
Scalability ensures you can adapt your systems as projects move from exploratory phases to regulatory submissions, providing continuity and reliability regardless of your team’s focus.
Regulatory-friendly systems lend credibility to your data and support your lab’s long-term success in meeting industry standards.
Selecting the right automated immunoassay platform requires balancing flexibility, precision, and scalability. Closed platforms deliver standardization and consistency, while open systems champion adaptability and innovation. Scalability across development stages, and regulatory compliance further define a system’s capabilities to enhance your bioprocess workflows.
With automation, you can reduce manual workloads, improve reproducibility, and ultimately make faster, better-informed decisions for your projects. By understanding your unique lab requirements and matching them to the strengths of an immunoassay platform, your team gains the tools needed to innovate with confidence.
Are you ready to simplify workflows while scaling results? By focusing on the right factors, the perfect immunoassay platform for your needs could be just a step away.